ArticleThe American journal of emergency medicine2025
Differentiating Type 1 and Type 2 myocardial infarction using a machine learning algorithm and biomarkers.
Article in The American journal of emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Utility of biomarkers in patients with a type 2 myocardial infarction: a systematic review.Open heart · 2026Pooled it
- Diagnostic performance of the Myocardial-Ischaemic-Injury index machine-learning algorithm in patients with an initial indeterminate troponin.Open heart · 2026Trial
- Contemporary Challenges and Strategies for Diagnosing and Managing in Type 2 Myocardial Infarction: A Narrative Review.Journal of personalized medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundTreatment of myocardial infarction (MI) differs based on MI type, which can be difficult to determine in the emergency department. This study sought to evaluate whether a machine learning algorithm (MI
methodsWe conducted a secondary analysis of the multisite CMR-IMPACT trial, which prospectively enrolled adults with symptoms of acute coronary syndrome and an initial indeterminate troponin. Patients with an adjudicated diagnosis of MI and an initial high-sensitivity cardiac troponin I (hs-cTnI; Abbott Laboratories) measure were included. Incidence of MI and MI type were adjudicated by expert reviewers. Receiver operator characteristic curves for MI-type were created and area under the curve (AUC) calculated for MI
resultsAmong 123 patients with adjudicated MI, the mean age was 60±12 years and 37.4% (46/123) were female. Type 1 MI occurred in 58.5% (72/123) and type 2 MI in 41.5% (51/123). MI
conclusionAdding NT-proBNP and Gal-3 to the MI
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.